These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 34100394)
1. Prediction of pharmacokinetic values of two various dosages of caffeine in premature neonates with apnea. Faramarzi F; Shiran M; Rafati M; Farhadi R; Salehifar E; Nakhshab M Indian J Pharmacol; 2021; 53(2):108-114. PubMed ID: 34100394 [TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetic study of caffeine citrate in Chinese premature infants with apnea. Guo A; Zhu Z; Xue J; Di X; Fan J; Huang L; Zhao P; Hu X; Xie H J Clin Pharm Ther; 2020 Dec; 45(6):1414-1421. PubMed ID: 32737938 [TBL] [Abstract][Full Text] [Related]
3. Dried blood spots and sparse sampling: a practical approach to estimating pharmacokinetic parameters of caffeine in preterm infants. Patel P; Mulla H; Kairamkonda V; Spooner N; Gade S; Della Pasqua O; Field DJ; Pandya HC Br J Clin Pharmacol; 2013 Mar; 75(3):805-13. PubMed ID: 22822712 [TBL] [Abstract][Full Text] [Related]
4. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring. Charles BG; Townsend SR; Steer PA; Flenady VJ; Gray PH; Shearman A Ther Drug Monit; 2008 Dec; 30(6):709-16. PubMed ID: 19057373 [TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity. Lee TC; Charles B; Steer P; Flenady V; Shearman A Clin Pharmacol Ther; 1997 Jun; 61(6):628-40. PubMed ID: 9209245 [TBL] [Abstract][Full Text] [Related]
6. Caffeine in apnoeic Asian neonates: a sparse data analysis. Lee HS; Khoo YM; Chirino-Barcelo Y; Tan KL; Ong D Br J Clin Pharmacol; 2002 Jul; 54(1):31-7. PubMed ID: 12100222 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea. Ahn HW; Shin WG; Park KJ; Suh OK; Choi JH Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):105-13. PubMed ID: 10850374 [TBL] [Abstract][Full Text] [Related]
8. Saliva as a valid alternative to serum in monitoring intravenous caffeine treatment for apnea of prematurity. Lee TC; Charles BG; Steer PA; Flenady VJ Ther Drug Monit; 1996 Jun; 18(3):288-93. PubMed ID: 8738770 [TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetic modeling of caffeine in preterm infants with apnea of prematurity: New findings from concomitant erythromycin and AHR genetic polymorphisms. Dai HR; Liu Y; Lu KY; He X; Guo HL; Hu YH; Xu J; Ding XS; Chen F; Cheng R; Jiao Z Pharmacol Res; 2022 Oct; 184():106416. PubMed ID: 36029933 [TBL] [Abstract][Full Text] [Related]
10. Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates. Koch G; Datta AN; Jost K; Schulzke SM; van den Anker J; Pfister M J Pediatr; 2017 Dec; 191():50-56.e1. PubMed ID: 29173321 [TBL] [Abstract][Full Text] [Related]
11. Developmental aspects of percutaneous caffeine absorption in premature infants. Amato M; Hüppi P; Isenschmid M; Schneider H Am J Perinatol; 1992; 9(5-6):431-4. PubMed ID: 1418150 [TBL] [Abstract][Full Text] [Related]
12. Association of Caffeine Daily Dose With Respiratory Outcomes in Preterm Neonates: A Retrospective Cohort Study. Rauf S; Shah S; Bibi Z; Munir R; Jiskani H; Ahmad S; Mir Shah SA; Bibi A; Fasih Ahmad H; Hussain K; Ariff S; Ambreen G Inquiry; 2024; 61():469580241248098. PubMed ID: 38666733 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic aspects of caffeine in premature infants. De Carolis MP; Romagnoli C; Muzii U; Tortorolo G; Chiarotti M; De Giovanni N; Carnevale A Dev Pharmacol Ther; 1991; 16(3):117-22. PubMed ID: 1914785 [TBL] [Abstract][Full Text] [Related]
14. Developmental population pharmacokinetics of caffeine in Chinese premature infants with apnoea of prematurity: A post-marketing study to support paediatric labelling in China. Gao XB; Zheng Y; Yang F; Wang CH; Jiang ZH; Wu YE; Jacqz-Aigrain E; Ni SQ; Zhao W Br J Clin Pharmacol; 2021 Mar; 87(3):1155-1164. PubMed ID: 32687613 [TBL] [Abstract][Full Text] [Related]
15. Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population. Abduljalil K; Pan X; Pansari A; Jamei M; Johnson TN Clin Pharmacokinet; 2020 Apr; 59(4):501-518. PubMed ID: 31587145 [TBL] [Abstract][Full Text] [Related]
16. The Pharmacokinetics of Caffeine in Preterm Newborns: No Influence of Doxapram but Important Maturation with Age. Engbers AGJ; Völler S; Poets CF; Knibbe CAJ; Reiss IKM; Koch BCP; Flint RB; Simons SHP Neonatology; 2021; 118(1):106-113. PubMed ID: 33626528 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise? Natarajan G; Botica ML; Thomas R; Aranda JV Pediatrics; 2007 May; 119(5):936-40. PubMed ID: 17473094 [TBL] [Abstract][Full Text] [Related]
18. [Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants]. Zhao Y; Tian X; Liu G Zhonghua Er Ke Za Zhi; 2016 Jan; 54(1):33-6. PubMed ID: 26791921 [TBL] [Abstract][Full Text] [Related]
19. Correlation between plasma and urinary caffeine levels in preterm infants. Cattarossi L; Violino M; Macagno F; Logreco P; Savoia M J Perinat Med; 2006; 34(4):344-6. PubMed ID: 16856829 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Different Maintenance Doses of Caffeine Citrate for Treatment of Apnea in Premature Infants: A Systematic Review and Meta-Analysis. Chen J; Jin L; Chen X Biomed Res Int; 2018; 2018():9061234. PubMed ID: 30671477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]